TP53 and B-cell chronic lymphocytic leukemia: Of note, a subset of patients with Richter transformation may in fact have relatively favorable outcomes akin to de novo DLBCL, particularly if they have previously untreated CLL, TP53 intact and clonally-unrelated Richter transformation, and demonstrate a complete response to R-CHOP (165–167).